The SAC inhibits CDC20 by promoting its association with three other proteins, MAD2, BUB3 and BUBR1 (also known as BUB1B and, in fission yeast, as Mad3), which leads to the formation of an MCC 21 . A rate-limiting step in MCC assembly is the binding of CDC20 to MAD2. This process requires conversion of MAD2 from an open (MAD2 O ) to a closed conformation (MAD2 C ) in which MAD2 C stably embraces CDC20 through a 'safety belt' mechanism 22, 23 . The generation of CDC20-MAD2 C complexes occurs at checkpoint-active kinetochores to which MAD2 C is recruited by binding to MAD1. This MAD1-MAD2 C complex promotes conversion of MAD2 O to MAD2 C and binding of the latter to CDC20. This process is thought to require the transient formation of a conformational MAD2 O -MAD2 C heterodimer, in which MAD2 O is recruited to the MAD2 C subunit of the kinetochoreassociated MAD1-MAD2 C complex 24, 25 .
The SAC inhibits CDC20 by promoting its association with three other proteins, MAD2, BUB3 and BUBR1 (also known as BUB1B and, in fission yeast, as Mad3), which leads to the formation of an MCC 21 . A rate-limiting step in MCC assembly is the binding of CDC20 to MAD2. This process requires conversion of MAD2 from an open (MAD2 O ) to a closed conformation (MAD2 C ) in which MAD2 C stably embraces CDC20 through a 'safety belt' mechanism 22, 23 . The generation of CDC20-MAD2 C complexes occurs at checkpoint-active kinetochores to which MAD2 C is recruited by binding to MAD1. This MAD1-MAD2 C complex promotes conversion of MAD2 O to MAD2 C and binding of the latter to CDC20. This process is thought to require the transient formation of a conformational MAD2 O -MAD2 C heterodimer, in which MAD2 O is recruited to the MAD2 C subunit of the kinetochoreassociated MAD1-MAD2 C complex 24, 25 .
MCC can associate with the APC/C, but unlike APC/C CDC20 , APC/C MCC is unable to bind and ubiquitylate securin and B-type cyclins 11 . MCC might inhibit CDC20 through multiple mechanisms: a KEN box in Mad3 occupies the KEN box-receptor site on Cdc20 (refs. 20,26) , another Mad3 domain might partially block a putative D-box-receptor site on Cdc20 (ref. 20) , and CDC20 occupies different positions on the APC/C in the presence or absence of the other MCC subunits 11 . To allow APC/C activation, MCC therefore has to be replaced by CDC20. Several studies have observed that this depends on MCC disassembly (described below). MCC disassembly is an
The spindle assembly checkpoint (SAC) delays chromosome segregation until all chromosomes are bi-oriented on the mitotic or meiotic spindle (reviewed in ref. 1) . Defects in this surveillance mechanism can lead to chromosome mis-segregation and aneuploidy, a condition associated with congenital trisomies, tumorigenesis and aging. The checkpoint is activated in prometaphase by chromosomes whose kinetochores are not attached or are incorrectly attached to microtubules 2, 3 . The checkpoint inhibits CDC20, a protein that associates with and activates the APC/C in mitosis [4] [5] [6] [7] [8] . APC/C initiates chromosome segregation by ubiquitylating securin, an inhibitor of the protease separase, and B-type cyclins, activators of cyclin-dependent kinase 1 (CDK1). The subsequent degradation of these proteins by the 26S proteasome leads to activation of separase, which destroys sister-chromatid cohesion and thereby initiates anaphase (reviewed in ref. 9) .
The APC/C is a 1.5-MDa protein complex composed of three structural domains, called the 'arc lamp' , the 'platform' and the 'catalytic core' 10, 11 . The latter domain contains the cullin APC2 and the RING finger subunit APC11 (refs. 10,12) . APC11 interacts with ubiquitin-conjugating (E2) enzymes and thereby facilitates the transfer of activated ubiquitin residues from the E2 to APC/C substrates [13] [14] [15] . Substrates contain APC/C recognition sequences, called the destruction box (D box) 16 and KEN box 17 . These 'degrons' are thought to be simultaneously recognized by the APC/C subunit APC10 and either CDC20 or CDH1, a CDC20-related coactivator protein that associates with the APC/C in late mitosis and G1 phase 12,18-20 . APC15 mediates CDC20 autoubiquitylation by APC/C MCC and disassembly of the mitotic checkpoint complex and CDC27 immunoprecipitates were able to support cyclin-B1 ubiquitylation reactions to similar extents (Fig. 1d) . Further analysis revealed that C11ORF51 is associated with APC/C in cells synchronized in G1, S, G2 and prometaphase (Fig. 1e) . These observations indicate that C11ORF51 is a bona fide subunit of the human APC/C.
We next tested whether C11ORF51 is related to subunits of APC/C that have so far only been identified in lower eukaryotes, for example Apc9 or Mnd2 (Apc15) in budding yeast 45, 46 . The sequence of C11ORF51 is well conserved among metazoans, ranging from cnidarians to mammals. We used a hidden Markov model (HMM) obtained by multiple sequence alignment of these sequences to search for related proteins in fungal and plant proteomes. We identified sequences significantly related to metazoan C11ORF51 in plants and fungi, with the closest relative of C11ORF51 in Schizosaccharomyces pombe being Apc15, an ortholog of Saccharomyces cerevisiae Mnd2 (Supplementary Fig. 1a,b) . A reciprocal search in the human, mouse and Arabidopsis thaliana energy-dependent process 27, 28 , possibly because spontaneous release of CDC20 from MAD2 would be too slow to allow rapid APC/C activation in metaphase 29 .
Several mechanisms have been discussed for how MCC may be disassembled. A previous study proposed that CDC20 autoubiquitylation by APC/C MCC leads to MCC disassembly 27 . However, this view has been challenged by another study that observed that CDC20 is continuously synthesized and degraded during prometaphase and proposed that ubiquitin-mediated CDC20 degradation is required to keep CDC20 levels below a threshold that would over-ride the checkpoint 30 . Several studies have shown that MCC disassembly depends on CUEDC2 (ref. 31 ) and p31(comet) 27, 29, [32] [33] [34] and that CDK1-mediated phosphorylation of these proteins and of CDC20 promotes MCC disassembly 31, 35 . CUEDC2's mechanism of action is unknown, but p31(comet) structurally mimics MAD2 O , and it can therefore bind to MAD2 C (refs. 36,37) . This interaction might facilitate dissociation of MAD2 C from CDC20.
Here we have characterized the function of C11ORF51, a protein required for mitotic progression 38 and associated with the APC/C 39 . We show that C11ORF51 is a subunit of APC/C's platform domain and is located near the MCC-binding site on the APC/C 11 . As recently reported by another study 40 , we find that depletion of C11ORF51, which has been renamed APC15, reduces the rate of MCC disassembly. In addition, we show for the first time, to our knowledge, that APC15 is required for efficient ubiquitylation of CDC20 as part of APC/C MCC and for CDC20 degradation in prometaphase, even though APC15 is not required for substrate ubiquitylation by APC/C CDC20 or APC/C CDH1 . Our results support the view 27, 29 that CDC20 autoubiquitylation contributes to MCC disassembly and that continuous CDC20 synthesis and degradation facilitates rapid APC/C activation in metaphase. In this study, we also report the first generation and characterization, to our knowledge, of recombinant human APC/C, assembled from 14 core subunits and either CDC20 or CDH1. results c11orF51 (aPc15) is a subunit of aPc/c's platform domain As part of the MitoCheck project, we performed a large-scale proteomic study to identify and characterize protein complexes required for mitosis in human cells 41 . This led to the discovery of two previously unknown APC/C interactors, chromosome 10 open reading frame 104 (C10ORF104; ref. 41) and chromosome 11 open reading frame 51 (C11ORF51; ref. 39) . C10ORF104 is an 11.7-kDa subunit of APC/C's arc-lamp domain and is now called APC16 (refs. 41,42) .
To test whether C11ORF51 is also a subunit of the APC/C, we raised antibodies to this protein. In addition we tagged human C11ORF51 with a sequence encoding a C-terminal localization affinity-purification (LAP) tag, which contains enhanced green fluorescent protein (EGFP) 43, 44 , and generated HeLa cells that stably express C11ORF51-LAP. When APC/C was immunoprecipitated from these cells by using CDC27 antibodies, both endogenous and LAP-tagged C11ORF51 could be detected by immunoblotting (Fig. 1a) , and the bands showed migration rates corresponding to 20 kDa and 55 kDa, respectively. Depletion of endogenous C11ORF51 with four different short interfering RNAs (siRNAs) confirmed that the 20-kDa band recognized by our antibodies corresponds to C11ORF51.
When C11ORF51-LAP was isolated by tandem affinity purification from HeLa cells and analyzed by mass spectrometry, peptides from ten APC/C subunits and CDC20 were identified, which confirmed that C11ORF51 is specifically associated with the APC/C (Fig. 1b) . In addition, immunoprecipitates obtained with C11ORF51 antibodies contained a similar set of proteins as APC/C samples isolated with CDC27 antibodies, as seen by SDS-PAGE and silver staining (Fig. 1c) . The C11ORF51 Identi ed  protein  APC1  APC2  CDC27  APC4  APC5  CDC16  APC7  CDC23  APC10  CDC26  CDC20   40%  19%  45%  38%  44%  34%  42%  43%  30%  36% location is consistent with the possibility that human C11ORF51 is related to yeast Mnd2, given that a previous study 46 used an in vitro transcription-translation system and found that Mnd2 interacts with Apc1 and Apc5, which are components of the platform domain, and with Cdc23, which is located close to the platform 11, 47 .
aPc15 is required for anaphase A previous genome-wide RNA interference (RNAi) screen had shown that depletion of C11ORF51 (APC15) delays mitotic progression 38 . To analyze the function of APC15 further, we depleted this protein by RNAi in HeLa cells stably expressing the histone H2B tagged with mCherry (H2B-mCherry) and β-tubulin tagged with the LAP tag (TUBB-LAP) and performed time-lapse fluorescence microscopy analysis (Fig. 2a) .
proteomes with an HMM derived from an alignment of S. pombe and Agaricomycetes Apc15 confirmed that C11ORF51 in metazoans is related to Mnd2 in fungi. It is therefore possible that C11ORF51 and Mnd2 are derived from a common ancestral APC/C subunit. As did a previous study 40 , we will refer to C11ORF51 as APC15.
To analyze where APC15 is located within the APC/C, we labeled purified human APC/C with APC15 antibodies under conditions that induce antibody-dependent APC/C dimerization [10] [11] [12] , isolated the APC/C dimers by density-gradient centrifugation and analyzed them by negative-staining electron microscopy ( Supplementary Fig. 1c,d ). The angular orientation of APC/C monomers within the dimers indicates that APC15 is part of APC/C's platform domain, where it might be located in close vicinity to APC4, APC5 and APC1 (Fig. 1f) . This Because a previous study 27 had found that MCC disassembly in cell extracts depends on APC/C activity, and APC15 could be required for APC/C activity, we next asked whether APC15 depletion might decrease MCC disassembly. We released APC15-depleted HeLa cells from nocodazole arrest and determined the levels of CDC20, MAD2 and BUBR1 on the APC/C over time. In control cells, the majority of MAD2 and BUBR1 was removed from the APC/C 90 min after the release (Fig. 4a, lane 10; Fig. 4b, lane 2) . At that time, cells had begun to exit mitosis, as evidenced by a decrease in cyclin-B1 and an increase in the electrophoretic mobility of CDC27, indicative of its dephosphorylation (Fig. 4a, lane 2; Fig. 4b, lane 2) . In contrast, in cells depleted of APC15, the levels of CDC20, MAD2 and BUBR1 remained high on the APC/C 90 min after the release (Fig. 4a , lane 13 compared to lane 14; Fig. 4b , lanes 5 and 6), and cyclin-B1 degradation and CDC27 dephosphorylation were reduced, though not abolished (Fig. 4a, lane 6;  Fig. 4b, lane 6) . Following APC15 depletion, all three MCC subunits could still be detected on the APC/C even 180 min after the release, although at greatly reduced levels (Fig. 4a, lane 15) . These results indicate that APC15 is required for rapid MCC disassembly.
To confirm this notion, we analyzed MCC disassembly in vitro by incubating immunopurified APC/C MCC with ubiquitin, the ubiquitinactivating enzyme E1 and the E2 enzyme UBCH10. Also in this assay, MCC disassembly was strongly decreased on APC/C MCC isolated from APC15-depleted cells (Fig. 4c, lanes 6-8) . These observations indicate that APC15 promotes progression through mitosis at least in part by facilitating MCC disassembly. We presently do not know whether the reduced rate of MCC disassembly observed in our assays is due to residual amounts of APC15 or whether MCC disassembly can also proceed slowly in the absence of APC15.
MCC disassembly depends on p31(comet) 29, [32] [33] [34] and proteasome activity 32, [48] [49] [50] . We compared the effects of APC15 depletion to the effects of p31(comet) depletion and proteasome inhibition. We released HeLa cells depleted of APC15 or p31(comet) or both from nocodazole arrest, in the presence or absence of proteasome inhibitor MG132 and analyzed CDC20, MAD2 and BUBR1 on the APC/C over time (Supplementary Fig. 3 ). APC15 depletion resulted in accumulation of In APC15-depleted cells, progression from nuclear-envelope breakdown (NEBD) to anaphase onset took more than twice as long as in control transfected cells, whereas progression from anaphase to cytokinesis was not significantly delayed (Fig. 2b) . Similar results were obtained when the APC/C subunit CDC16 was depleted (data not shown).
When fixed cells were analyzed by microscopy, we observed an increase in the number of prometaphase and metaphase cells following APC15 depletion (Fig. 2c and Supplementary Fig. 2 ), consistent with a delay during these stages of mitosis. We could also detect an increase in the frequency of cells in anaphase and telophase, perhaps due to the larger number of cells analyzed (n > 8,600) compared to the number used in generating the live-cell imaging data (n = 25). The increase in mitotic index that was observed after APC15 depletion was partly restored by co-depletion of MAD2, consistent with the notion that APC15 depletion delays mitotic progression by compromising APC/C function (Fig. 2d). aPc15 is required for aPc/c mcc disassembly Because APC/C is activated by CDC20 and inhibited by MAD2 and BUBR1, we asked whether APC15 depletion might alter APC/C function by affecting the steady-state levels of these proteins on the APC/C. Immunoblotting (Fig. 3a) or silver-staining (Fig. 3b) analyses revealed that the levels of all three proteins on the APC/C strongly increased following depletion of APC15, which indicated that APC15 depletion leads to accumulation of MCC on the APC/C. This effect was particularly evident when APC/C was isolated from cells that had been synchronized in prometaphase by nocodazole treatment (Fig. 3a, lane 8) , but it could also be observed to a lesser extent in APC/C samples from asynchronous cell populations (Fig. 3a, lane 6) . When MAD2 was co-depleted from cells at the same time as APC15, neither CDC20 nor BUBR1 accumulated on APC/C, which indicated that the increased binding of these proteins to the APC/C depends on the SAC (Fig. 3b, lane 7 compared to lane 8;  Fig. 3c, lane 15 compared to lane 16) .
To test whether the accumulation of CDC20, MAD2 and BUBR1 on the APC/C occurs specifically in mitosis, we released APC15-depleted cells from a thymidine-induced arrest in S phase, monitored cell cycle progression of cells stained with propidium iodide by fluorescenceactivated cell sorting (FACS) (Fig. 3d) and analyzed the amounts of these proteins on the APC/C by immunoblotting (Fig. 3e) . The strongest increase in CDC20, MAD2 and BUBR1 on the APC/C was observed a r t i c l e s npg subunits and (ii) an increase in the cellular concentration of CDC20. Because CDC20 is continuously synthesized and degraded during prometaphase 30 , we analyzed whether APC15 depletion might stabilize CDC20. As reported 30 , CDC20 levels decreased in prometaphasearrested cells when protein synthesis was inhibited by cycloheximide ( Fig. 5a, lanes 11-15) . This effect was reversed by MG132, which indicated that in cycloheximide-treated cells, CDC20 levels decrease due to proteolysis (Fig. 5a, lanes 6-10) . Notably, the rate of this proteolysis was reduced in cells depleted of APC15, which indicated that APC15 is required for rapid degradation of CDC20 in cells with an active SAC (Fig. 5b , lanes 6-10; quantified in Fig. 5c ).
aPc15 is dispensable for aPc/c cDc20 and aPc/c cDH1 activity One possible interpretation of the above results is that APC15 depletion would compromise APC/C activity, reducing CDC20 ubiquitylation and consequently delaying MCC disassembly. To test this possibility, we generated baculoviruses expressing all 14 subunits of the human APC/C, co-infected insect cells with them and isolated recombinant APC/C. The recombinant complexes contained a subunit pattern, as seen by much more MCC on APC/C than p31(comet) depletion did, although both treatments delayed MCC disassembly to a similar extent. It is possible that APC15 and p31(comet) were depleted to different degrees in our experiments or that p31(comet) acts catalytically in MCC disassembly and is therefore less sensitive to partial depletion than APC15, which is expected to function in a stoichiometric manner as an APC/C subunit. However, the different effects of APC15 and p31(comet) depletion are also consistent with the possibility that p31(comet) depletion affects MCC steady-state levels through two distinct mechanisms: (i) by 'capping' the MAD1-MAD2 C template at unattached kinetochores and thereby preventing MCC formation and (ii) by binding to MAD2 C as part of the MCC and thereby promoting MCC disassembly. In contrast, APC15 depletion might reduce MCC disassembly without slowing down MCC formation, thus leading to a more pronounced accumulation of MCC on the APC/C. These experiments also confirmed that proteasome inhibition delays MCC disassembly. Like p31(comet) depletion, MG132 treatment led to only a small increase in MCC levels on the APC/C. However, in this case, the difference relative to depleting APC15 is presumably because the proteasome had only been inhibited during the last 3 h of the experiment, whereas cells had been gradually depleted of APC15 for a much longer period of time (48 h), during which MCC was able to accumulate. These observations indicate that MCC disassembly depends on at least three components: APC15, p31(comet) and proteasome activity. aPc15 is required for cDc20 degradation in prometaphase APC15 depletion not only increased the amounts of CDC20 that were associated with the APC/C but also increased CDC20 steady-state levels in total cell lysates (Fig. 3a, lanes 2 and 4) . This was not, or was only to a much lesser degree, the case for MAD2 and BUBR1, which implies that APC15 depletion might have two different effects: (i) a change in the equilibrium between APC/C-associated and non-associated MCC a r t i c l e s npg CDC20 when this protein is part of APC/C MCC . This reaction may depend on different mechanisms than substrate ubiquitylation mediated by APC/C CDH1 and APC/C CDC20 , similarly to how Cdc20 ubiquitylation by APC/C Cdh1 and Cdc20 autoubiquitylation have been shown to differ in yeast 51 . Because we were so far not able to reconstitute APC/C MCC by using a fully recombinant system, we used APC/C MCC isolated from APC15-depleted cells. We confirmed the finding by a previous study 27 that incubation of isolated APC/C MCC with ubiquitin, E1 and UBCH10 resulted in ubiquitylation of CDC20 and in dissociation of MAD2 from APC/C MCC (Fig. 7a) . In contrast, CDC20 ubiquitylation was reduced when we used APC/C MCC from which APC15 had been depleted (Fig. 7b,  lanes 5-8) . This reduction was consistently observed in all seven independent experiments performed (Supplementary Fig. 5 ), even though more CDC20 was present in the APC/C MCC samples isolated from APC15-depleted cells than in samples containing wild-type APC/C MCC (Fig. 7b, APC4 immunoblot signals compared to CDC20 signals in the shorter immunoblot exposure), and depletion of APC15 by RNAi may have been incomplete. These results indicate that APC15 is required for the efficient ubiquitylation of CDC20 when this protein is part of MCC but not when CDC20 is a substrate of APC/C CDH1 .
Discussion
Because APC/C activity is essential for sister-chromatid separation and mitotic exit, APC/C has to be relieved from its inhibition by MCC once spindle assembly is completed. Here we confirm and extend the finding that C11ORF51 (APC15) is an APC/C subunit required for this event [38] [39] [40] . Notably, we show for the first time, to our knowledge, that APC15 is essential not only for rapid MCC disassembly but also for efficient CDC20 autoubiquitylation by APC/C MCC and for subsequent proteasomal degradation in cells with an active SAC. This correlation supports the view that CDC20 ubiquitylation and degradation facilitate rapid MCC disassembly and APC/C activation 27, 29 . Our results are not consistent with the proposal that CDC20 degradation maintains the checkpoint 30, 40 . We therefore favor the model that CDC20 is constantly autoubiquitylated by APC/C MCC and degraded in cells with an active checkpoint, which leads to continuous MCC disassembly. According to this hypothesis, APC/C inhibition can only be maintained as long as newly synthesized CDC20 is assembled into MCCs. Once MCC production has ceased, newly synthesized CDC20 would rapidly replace MCC on APC/C, leading to APC/C activation. As first proposed by a previous study 29 , checkpoint inhibition of the APC/C may therefore be achieved not by stable association of MCC with APC/C but by a dynamic equilibrium of MCC assembly and disassembly, which would lead to continuous turnover of MCC on APC/C. This hypothesis has the potential to explain why CDC20 is continuously synthesized and degraded during prometaphase 30 and how APC/C is activated rapidly and by default in metaphase, although MAD2 binds to CDC20 tightly during prometaphase. The hypothesis also provides a rationale for a number of previous observations, such as the fact that inhibition of the proteasome leads to accumulation of MCC on APC/C 11, 32, [48] [49] [50] . Notably, the MCC-turnover hypothesis also implies that MCC's association with the APC/C is not only required for APC/C inhibition, as was previously assumed, but also may have the opposite function, namely to overcome APC/C's inhibition by MCC.
What may be the role of APC15 in this process? As a subunit of the APC/C, APC15 could simply be required for the ubiquitylation activity of the APC/C. However, we found that recombinant forms of human APC/C CDH1 , whose generation we report here, can ubiquitylate both cyclin-B1 and CDC20 similarly well in the presence or absence of APC15, which implies that APC/C's ubiquitylation activity per se does not strictly depend on APC15. On the contrary, the ability of APC/C MCC SDS-PAGE (Fig. 6a) , that is reminiscent of APC/C purified from HeLa cells. Single-particle electron microscopy and angular reconstitution revealed that, at the resolution obtained, the overall shape of the recombinant complexes is indistinguishable from those of the threedimensional (3D) models we have previously obtained for endogenous human APC/C ( Fig. 6b; refs. 11,12) . Furthermore, the recombinant complexes were able to ubiquitylate an N-terminal fragment of cyclin-B1 in a CDH1-dependent manner (Fig. 6c, lanes 6 and 7) . Recombinant APC/C lacking APC11 was unable to mediate ubiquitylation reactions, which confirmed that this activity was attributable to human APC/C (Supplementary Fig. 4) . These results indicate that the recombinant human APC/C which we have generated here is functional and similar in its properties to endogenous APC/C.
Next we generated recombinant APC/C lacking APC15 (Fig. 6a) . To exclude that an APC15-related protein from insect host cells (from the moth Spodoptera frugiperda) could substitute for human APC15, we analyzed our sample by mass spectrometry and searched for peptides derived from the sequence of S. frugiperda APC15, which we had identified by BLAST searches (Supplementary Fig. 1a) . No peptides from S. frugiperda APC15 could be detected (data not shown). Human APC/C can therefore be assembled in the complete absence of APC15. Nevertheless, recombinant APC/C lacking APC15, after incubation with CDH1, was similarly active in supporting the formation of cyclin-B1 and CDC20 ubiquitin conjugates as wild-type APC/C (Fig. 6c,d ). Similar observations were made in ubiquitylation assays using a ubiquitin fusion to the cyclin-B1 fragment as a substrate to specifically assay E2 enzyme UBE2S instead of UBCH10 and in assays using CDC20 instead of CDH1 (Supplementary Fig. 4c ).
aPc15 mediates cDc20 autoubiquitylation by aPc/c mcc Although our data cannot exclude the possibility that APC15 has an effect on kinetic properties of ubiquitylation reactions that cannot be detected by our assays, our results also show unequivocally that APC15 is not essential for the ubiquitylation activity of APC/C CDH1 and APC/C CDC20 . We thus tested whether APC15 is required for the ubiquitylation of to autoubiquitylate CDC20 is reduced after depletion of APC15, which indicates that APC15 has a specific role in this process that is dispensable for substrate ubiquitylation by APC/C CDH1 and APC/C CDC20 . The location of APC15 in the platform domain may provide a rationale for this phenomenon, as our results indicate that APC15 is located in the vicinity of MCC's binding site. APC15 could therefore be required for proper positioning of MCC on the APC/C, an effect that could be required for CDC20 autoubiquitylation. Alternatively, APC15 could have effects on the catalytic core of the APC/C, and these effects could be required for CDC20 autoubiquitylation but dispensable for conventional substrate ubiquitylation. Notably, APC15 is distantly related to Mnd2, an APC/C subunit that had previously been identified only in budding yeast and other fungi. This finding confirms the notion that APC/C is highly conserved among eukaryotes, a phenomenon that presumably reflects the early appearance of APC/C during evolution and the importance of APC/C's function and its tight regulation. Unlike APC15, Mnd2 was so far only known to have a role in meiosis I, in which Mnd2 functions as an inhibitor of the meiosis-specific APC/C coactivator Ama1 (refs. 52,53) . However, because Ama1 is related in structure and function to CDC20, it is conceivable that Mnd2 and APC15 share the ability to control some property of APC/C coactivator proteins, a phenomenon that in the case of Mnd2 may lead to inactivation of Ama1 and in the case of APC15 to disassembly of MCC. It will, therefore, be interesting to test whether Mnd2 inhibits Ama1 by a mechanism that depends on Ama1 autoubiquitylation by APC/C Ama1 , similarly to how the presence of APC15 enables CDC20 autoubiquitylation by APC/C MCC . Consistent with this possibility, and supporting the notion that APC15 and Mnd2 perform related functions, another study reported, after submission of this manuscript, that Mnd2 is also required for MCC-dependent Cdc20 autoubiquitylation and SAC inactivation in mitotic yeast cells 54 . 
